Dr Boreham's Crucible: Orthocell

Micro-cap biotech Orthocell is aiming to emulate the successful growth story of Polynovo, nowadays capitalised at $1.1bn

Related Keywords

Perth ,Western Australia ,Australia ,Alabama ,United States ,Ming Hao Zheng ,Qi Xiao Zhou ,Matthew Callahan ,Paul Anderson Nicole Telford ,Minghao Zheng ,Tim Boreham ,Henry Schein ,Lars Lidgren ,Paul Anderson ,Qixiao Zhou ,Jia Xun Xu ,Drug Administration ,Therapeutic Goods Administration ,Small Caps ,Prof Lars Lidgren ,Nicole Telford ,Biohorizon Implant Systems ,Prof Ming Hao Zheng ,Prof Zheng ,